Novartis Pharmaceuticals Head to Depart Amid Restructuring – Wall Street Journal
Updated May 17, 2016 2:41 p.m. ET Novartis AG NVS 0.11 % said its head of pharmaceuticals, David Epstein, is to leave the company amid a restructuring that will split his role in two. The Basel, Switzerland-based drug giant said Mr. Epstein, who is American, had decided to leave the company to explore new challenges…
Details